Nevirapine versus atazanavir/ritonavir, each combined with tenofovir disoproxil fumarate/emtricitabine, in antiretroviral-naive HIV-1 patients: the ARTEN Trial (Q59709783)
Jump to navigation
Jump to search
article
Language | Label | Description | Also known as |
---|---|---|---|
English | Nevirapine versus atazanavir/ritonavir, each combined with tenofovir disoproxil fumarate/emtricitabine, in antiretroviral-naive HIV-1 patients: the ARTEN Trial |
article |
Statements
Nevirapine versus atazanavir/ritonavir, each combined with tenofovir disoproxil fumarate/emtricitabine, in antiretroviral-naive HIV-1 patients: the ARTEN Trial (English)
Keikawus Arastéh
Horacio Migrone
Thomas Lutz
Milos Opravil
Jaime Andrade-Villanueva
Giovanni Di Perri
Daniel Podzamczer
Steve Taylor
Pere Domingo
Holger Gellermann
Lothar de Rossi
ARTEN investigators
1 January 2011